NuCube Energy | $13,000,000 | (Feb 20, 2026)
Ownwell | $50,000,000 | (Feb 20, 2026)
PolyGone Systems Inc | $4,000,000 | (Feb 20, 2026) Certified by Founder
Lodge
Addition Therapeutics
start up
United States
- South San Francisco, California
- 18/12/2025
- Unknown
- $100,000,000
Addition Therapeutics is on a mission to fulfill the transformative promise of genomic medicine for people impacted by both chronic and rare diseases. Leveraging our breakthrough all-RNA, non-viral, LNP-based PRINT™ platform, we are overcoming the limitations of existing genetic medicine modalities to develop safer, durable, one-time therapies. Bolstered by our team of top-tier scientists and engineers, we are advancing a robust pipeline of PRINTed therapeutics that have the potential to fundamentally redefine how chronic and rare diseases are treated. Our investor syndicate includes SR One, Pivotal Life Sciences, Abingworth, Osage University Partners, the Gates Foundation, and BEVC.
- Industry Biotechnology Research
- Website https://additiontx.com/
- LinkedIn https://www.linkedin.com/company/addition-therapeutics/
Altesa BioSciences, Inc. | $75,000,000 | (Feb 20, 2026)
SPRX | $31,000,000 | (Feb 20, 2026)
Adronite | $5,000,000 | (Feb 20, 2026)
Odynn | $9,500,000 | (Feb 20, 2026)
Ascent(US) | $45,000,000 | (Feb 20, 2026)
Badge | $17,100,000 | (Feb 20, 2026)
Sift Biosciences | $3,700,000 | (Feb 19, 2026)
Avantos.ai | $25,000,000 | (Feb 19, 2026)
Korsana Biosciences | $175,000,000 | (Feb 19, 2026)